Vitro Biopharma, Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q4 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Vitro Biopharma, Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q4 2021 to Q4 2023.
  • Vitro Biopharma, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending January 31, 2024 was $4.89K, a 15.6% decline year-over-year.
  • Vitro Biopharma, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $21.6K, a 63.8% decline from 2022.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $4.89K -$902 -15.6% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-14
Q4 2022 $5.8K +$2.88K +98.6% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-14
Q4 2021 $2.92K Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.